Discover SIMLANDI, FDA-approved, high-concentration, citrate-free biosimilar to Humira. See safety info.

May 1, 2025 · Simlandi (adalimumab-ryvk) is an interchangeable biosimilar of Humira used for autoimmune conditions plaque psoriasis, Crohn's disease, ulcerative colitis, rheumatoid …

Patients with TB have frequently presented with disseminated or extrapulmonary disease. Test patients for latent TB before SIMLANDI use and during therapy. Initiate treatment for latent TB …

Adalimumab is used to reduce pain and swelling due to certain types of arthritis (such as rheumatoid, psoriatic, juvenile idiopathic, ankylosing spondylitis). This medication is also used …

Sep 1, 2025 · Learn about SIMLANDI® | The first FDA-approved biosimilar interchangeable for the most widely prescribed formulation of Humira®: high concentration & citrate free.

Nov 23, 2025 · Simlandi package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

Simlandi (Cf) Autoinjector Frequently Asked Questions What are the most important Simlandi (Cf) Autoinjector warnings? This medication can decrease your body's ability to fight an infection. …

A patient may self-inject SIMLANDI or a caregiver may inject SIMLANDI using the SIMLANDI autoinjector if a physician determines that it is appropriate, and with medical follow-up, as …

Sep 3, 2024 · Simlandi (Adalimumab-ryvk Injection, for Subcutaneous Use) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications …

Jun 18, 2024 · Simlandi (adalimumab or adalimumab-ryvk) is an injectable medication used to treat many autoimmune conditions, including rheumatoid arthritis, Crohn's disease, and plaque …